Ningbo David Medical Device Co., Ltd. (SHE:300314)
China flag China · Delayed Price · Currency is CNY
14.60
-0.37 (-2.47%)
Nov 13, 2026, 3:04 PM CST

SHE:300314 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
607.26578.62516.93606.83496.58469.87
Other Revenue
5.415.4110.111.479.464.26
612.67584.03527.03618.3506.04474.13
Revenue Growth
18.56%10.82%-14.76%22.18%6.73%3.18%
Cost of Revenue
309.94273.01233.47263.61210.28185.25
Gross Profit
302.73311.02293.55354.68295.76288.88
Selling, General & Admin
171.85174.81172.44172.15155.19166.5
Research & Development
52.6459.355.4648.0645.8749.69
Other Operating Expenses
9.084.565.036.727.986.81
Operating Expenses
233.09239.96233.16227.43210.26223.27
Operating Income
69.6471.0660.39127.2585.565.61
Interest Expense
-0.3-0.43-0.47-0.6-0.35-0.03
Interest & Investment Income
16.2125.8410.7125.875.3918.9
Currency Exchange Gain (Loss)
-5.72-5.720.836.3317.05-2.86
Other Non Operating Income (Expenses)
-18.1-0.48-0.46-0.3-0.27-0.23
EBT Excluding Unusual Items
61.7390.2771.01158.55107.3181.38
Impairment of Goodwill
---0.52-1.53--
Gain (Loss) on Sale of Investments
35.951.78-10.060.26-4.880.69
Gain (Loss) on Sale of Assets
0.02-0.39-0.01-0.230.020.12
Asset Writedown
-1.49-0.02-0.01-0.08-0.02-0.04
Other Unusual Items
7.027.022.989.249.495.05
Pretax Income
103.2498.6663.38166.22111.9287.19
Income Tax Expense
11.111.66.1218.6114.566.99
Net Income
92.1387.0557.26147.6197.3680.21
Net Income to Common
92.1387.0557.26147.6197.3680.21
Net Income Growth
38.39%52.02%-61.21%51.62%21.39%-41.11%
Shares Outstanding (Basic)
290290286289286286
Shares Outstanding (Diluted)
290290286289286286
Shares Change
1.32%1.35%-1.08%1.08%-0.04%-1.14%
EPS (Basic)
0.320.300.200.510.340.28
EPS (Diluted)
0.320.300.200.510.340.28
EPS Growth
36.59%50.00%-60.78%50.00%21.43%-40.43%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
54.8634.22-45.8294.8161.7944.95
Free Cash Flow Per Share
0.190.12-0.160.330.220.16
Dividend Per Share
0.0800.0800.0870.1800.1500.100
Dividend Growth
-8.05%-8.05%-51.67%20.00%50.00%-33.33%
Gross Margin
49.41%53.25%55.70%57.36%58.45%60.93%
Operating Margin
11.37%12.17%11.46%20.58%16.89%13.84%
Profit Margin
15.04%14.91%10.87%23.87%19.24%16.92%
Free Cash Flow Margin
8.95%5.86%-8.70%15.33%12.21%9.48%
EBITDA
88.8992.4884.68154.57108.9389.76
EBITDA Margin
14.51%15.83%16.07%25.00%21.53%18.93%
D&A For EBITDA
19.2521.4124.2927.3223.4324.15
EBIT
69.6471.0660.39127.2585.565.61
EBIT Margin
11.37%12.17%11.46%20.58%16.89%13.84%
Effective Tax Rate
10.76%11.76%9.65%11.20%13.01%8.01%
Revenue as Reported
612.67584.03527.03618.3506.04474.13
Advertising Expenses
-9.383.224.513.324.06